BIOFORCE NANOSCIENCES HOLDINGS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.3M | $-490.4K | $-472.0K | $-485.5K | $-502.0K | $-158.4M | $-46.5K | $-67.7K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-65.2K | $-61.3K | $-46.7K | $-68.4K | $-77.8K | $-80.2K | $-24.4K | $-62.5K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $65.1K | $61.5K | $46.6K | $58.0K | $49.0K | $67.2K | $47.9K | — |
| Net Change in Cash | $-76 | $224 | $-96 | $-10.4K | $-28.8K | $-13.0K | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |
Know what you own, and know why you own it.